Advances survival time. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy12

Cell Line, Tumor Cells, Cultured Bile Ducts, Intrahepatic Tumor Cells, Cultured Spleen Brain Cell Line Lymph Nodes T-Lymphocytes Neurons Liver Lung

Organisms10

Mice, Inbred C57BL Mice, Inbred BALB C Mice, Nude Mice, Knockout Mice, Inbred Strains Mice, Transgenic Mice, SCID Mice, Inbred DBA Mice, Inbred C3H Dogs

Diseases56

Lung Neoplasms Brain Neoplasms Adenocarcinoma Neoplasm Recurrence, Local Liver Neoplasms Neoplasm Metastasis Carcinoma, Non-Small-Cell Lung Disease Progression Breast Neoplasms Glioblastoma Disease Models, Animal Carcinoma, Hepatocellular Colorectal Neoplasms Stomach Neoplasms Pancreatic Neoplasms Neoplasms Lymphatic Metastasis Carcinoma, Squamous Cell Glioma Carcinoma Ovarian Neoplasms Bile Duct Neoplasms Melanoma Neoplasm Invasiveness Carcinoma, Small Cell Recurrence Cholangiocarcinoma Esophageal Neoplasms Supratentorial Neoplasms Bone Neoplasms Kidney Neoplasms Pleural Neoplasms Leukemia L1210 Dog Diseases Mesothelioma Prostatic Neoplasms Carcinoma, Renal Cell Multiple Myeloma Neoplasms, Experimental Colonic Neoplasms Skin Neoplasms Astrocytoma Peritoneal Neoplasms Postoperative Complications Lymphoma Rectal Neoplasms Head and Neck Neoplasms Osteosarcoma Neovascularization, Pathologic Neutropenia Sarcoma Acute Disease Lymphoma, Non-Hodgkin Carcinoma, Ehrlich Tumor Leukemia, Experimental Ascites

Chemicals and Drugs48

Antineoplastic Agents Cisplatin Tumor Markers, Biological Fluorouracil Deoxycytidine Doxorubicin Cyclophosphamide Antimetabolites, Antineoplastic Paclitaxel Vincristine Etoposide Antibodies, Monoclonal Nimustine Leucovorin Camptothecin Carboplatin Dacarbazine Organoplatinum Compounds Antineoplastic Agents, Phytogenic Taxoids RNA, Messenger Antineoplastic Agents, Alkylating Vinblastine Prednisone Immunosuppressive Agents Neoplasm Proteins Antibodies, Monoclonal, Humanized Methotrexate Tegafur Oxonic Acid Oxyquinoline Proto-Oncogene Proteins Tumor Suppressor Protein p53 Recombinant Proteins Vindesine Survival of Motor Neuron 1 Protein Cytarabine Receptor, Epidermal Growth Factor Ki-67 Antigen Antibiotics, Antineoplastic Cytokines Quinazolines Receptor, erbB-2 Mitomycin Epirubicin Drug Combinations RNA, Small Interfering Protein Kinase Inhibitors

Analytical, Diagnostic and Therapeutic Techniques and Equipment91

Survival Rate Survival Analysis Disease-Free Survival Treatment Outcome Prognosis Kaplan-Meier Estimate Retrospective Studies Antineoplastic Combined Chemotherapy Protocols Neoplasm Staging Proportional Hazards Models Combined Modality Therapy Follow-Up Studies Immunohistochemistry Multivariate Analysis Drug Administration Schedule Disease Models, Animal Prospective Studies Risk Factors Cohort Studies Chemotherapy, Adjuvant Palliative Care Transplantation, Homologous Neoplasm Transplantation Predictive Value of Tests Risk Assessment Remission Induction Skin Transplantation Clinical Trials as Topic Radiotherapy, Adjuvant Infusions, Intravenous Radiotherapy Dosage Models, Biological Heart Transplantation Registries Liver Transplantation Chemoembolization, Therapeutic Gene Expression Profiling Reverse Transcriptase Polymerase Chain Reaction Actuarial Analysis Life Tables Salvage Therapy Immunotherapy Analysis of Variance Radiotherapy Probability Tumor Burden Xenograft Model Antitumor Assays Blotting, Western Neoplasm Grading Neoplasms, Experimental Hepatectomy Dose Fractionation Transplantation, Heterologous Kidney Transplantation Incidence Neoadjuvant Therapy Karnofsky Performance Status Chemoradiotherapy Chi-Square Distribution Corneal Transplantation Oligonucleotide Array Sequence Analysis Genetic Therapy Randomized Controlled Trials as Topic Cranial Irradiation Regression Analysis Treatment Failure Cause of Death Models, Statistical Life Expectancy Gastrectomy Tissue Array Analysis Clinical Trials, Phase III as Topic SEER Program Injections, Intraperitoneal Lethal Dose 50 Severity of Illness Index Random Allocation Tomography, X-Ray Computed Immunoenzyme Techniques Infusions, Intra-Arterial Patient Selection Administration, Oral Statistics, Nonparametric Biostatistics Clinical Trials, Phase II as Topic Dose-Response Relationship, Radiation Drug Therapy, Combination Leukemia, Experimental Reproducibility of Results Boron Neutron Capture Therapy Reoperation

Phenomena and Processes29

Cell Survival Graft Survival Time Factors Apoptosis Signal Transduction Graft Rejection Cell Proliferation Gene Expression Regulation, Neoplastic Dose-Response Relationship, Drug Mutation Drug Resistance, Neoplasm Longevity Probability Phenotype Cell Division Chi-Square Distribution Cell Differentiation Cell Death Gene Expression Lethal Dose 50 Genotype Up-Regulation Phosphorylation Drug Synergism Dose-Response Relationship, Radiation Microbial Viability Cell Movement Erythrocyte Aging Algorithms

Disciplines and Occupations1

Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena4

Survival Advance Directives Quality of Life Living Wills

Humanities1

Quality of Life

Information Science9

Survival Rate Registries Life Tables Incidence Cause of Death Life Expectancy SEER Program Molecular Sequence Data Algorithms

Named Groups1

Health Care45

Survival Rate Survival Analysis Disease-Free Survival Treatment Outcome Kaplan-Meier Estimate Retrospective Studies Advance Care Planning Advance Directives Proportional Hazards Models Follow-Up Studies Multivariate Analysis Prospective Studies Risk Factors Cohort Studies Palliative Care Age Factors Predictive Value of Tests Risk Assessment Clinical Trials as Topic Advance Directive Adherence Registries Actuarial Analysis Life Tables Analysis of Variance Probability Incidence Karnofsky Performance Status Chi-Square Distribution Randomized Controlled Trials as Topic Regression Analysis Treatment Failure Cause of Death Models, Statistical Life Expectancy Clinical Trials, Phase III as Topic SEER Program Severity of Illness Index Random Allocation Patient Selection Sex Factors Statistics, Nonparametric Living Wills Clinical Trials, Phase II as Topic Dose-Response Relationship, Radiation Reproducibility of Results

Geographicals2

United States Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Health Care Geographicals

Survival Rate Cell Survival Survival Analysis Disease-Free Survival Survival Graft Survival Treatment Outcome Prognosis Kaplan-Meier Estimate Time Factors Retrospective Studies Antineoplastic Combined Chemotherapy Protocols Neoplasm Staging Advance Care Planning Lung Neoplasms Advance Directives Proportional Hazards Models Combined Modality Therapy Follow-Up Studies Antineoplastic Agents Brain Neoplasms Cisplatin Adenocarcinoma Neoplasm Recurrence, Local Liver Neoplasms Tumor Markers, Biological Neoplasm Metastasis Carcinoma, Non-Small-Cell Lung Immunohistochemistry Multivariate Analysis Apoptosis Fluorouracil Disease Progression Breast Neoplasms Drug Administration Schedule Cell Line, Tumor Mice, Inbred C57BL Glioblastoma Deoxycytidine Disease Models, Animal Carcinoma, Hepatocellular Prospective Studies Risk Factors Colorectal Neoplasms Stomach Neoplasms Pancreatic Neoplasms Signal Transduction Doxorubicin Neoplasms Mice, Inbred BALB C Cyclophosphamide Lymphatic Metastasis Carcinoma, Squamous Cell Antimetabolites, Antineoplastic Cohort Studies Glioma Chemotherapy, Adjuvant Graft Rejection Palliative Care Age Factors Transplantation, Homologous Carcinoma Ovarian Neoplasms Cell Proliferation Paclitaxel Neoplasm Transplantation Predictive Value of Tests Gene Expression Regulation, Neoplastic Vincristine Dose-Response Relationship, Drug Mutation Risk Assessment Bile Duct Neoplasms Remission Induction Melanoma Etoposide Neoplasm Invasiveness Antibodies, Monoclonal Nimustine Carcinoma, Small Cell Skin Transplantation Recurrence Clinical Trials as Topic Leucovorin Cholangiocarcinoma Esophageal Neoplasms Camptothecin Carboplatin Radiotherapy, Adjuvant Infusions, Intravenous Supratentorial Neoplasms Dacarbazine Cells, Cultured Radiotherapy Dosage Models, Biological Advance Directive Adherence Organoplatinum Compounds Antineoplastic Agents, Phytogenic Heart Transplantation Registries

No FAQ available that match "advances survival time"